Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$163,868,130
+$109,312,193 QoQ
Shares Held
669,478
+107.4% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#10
of 503 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Jun 30, 2026CallValue
$1,076,988
CallShares
4,400
PutValue
$1,493,097
PutShares
6,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. AXSM ranks #9 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in AXSM
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,076,988 | 4,400 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $1,493,097 | 6,100 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $163,868,130 | 669,478 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $54,555,937 | 322,778 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $625,374 | 3,700 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $26,591,836 | 145,597 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $996,740 | 8,207 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $5,482,193 | 47,005 | Shares | Sole | 2025-05-15 | |
| 2022-09-30 | $6,305,341 | 141,312 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $2,188,454 | 52,874 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,497,294 | 92,570 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $698,752 | 21,200 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $9,161,172 | 161,801 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,295,373 | 15,900 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||